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To study the inhibition of the inwardly rectifying basolateral
50 pS potassium channels by PGE2 we performed
patch-clamp studies on the basolateral membrane of the
rat kidney thick ascending limb. PGE2’s effect was mimicked
by the selective EP1- and EP3-receptor agonist, sulprostone,
but was prevented by inhibiting protein kinase-C with
calphostin-C. The mitogen-activated protein kinase inhibitor
PD98059 (ERK) or SB203580 (p38) increased basal channel
activity; however, while neither alone prevented the
inhibitory effect of PGE2, but using both of them together
completely abolished PGE2’s effect on channel activity.
Treatment with PGE2 stimulated phosphorylation of both p38
and ERK in primary cultures of medullary thick ascending
limb cells. The PGE2-mediated mitogen-activated protein
kinase activation was not affected by indomethacin, but was
completely blocked by calphostin-C. These studies show that
inhibition of basolateral 50 pS potassium channels by PGE2
is mediated by protein kinase-C, which in turn stimulates
mitogen-activated protein kinases in the thick ascending
limb of the rat kidney.
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The thick ascending limb (TAL) is responsible for absorption
of 20–25% of the filtered NaCl load and plays a key role in the
ability of the kidney to concentrate urine.1–3 Potassium (K)
channels in the TAL are an important component for
maintaining the function of TAL: apical K channels are
essential for K recycling across the luminal membrane,4 while
basolateral K channels play a key role in generating the cell
membrane potential in the TAL.5 Several types of basolateral
K channels have been identified with patch-clamp experi-
ments.6,7 We and others have confirmed that a 50 pS inwardly
rectifying K channel was highly active in the basolateral
membrane. However, the regulatory mechanism of the 50 pS
K channels is not completely understood. We have demon-
strated previously that arachidonic acid inhibited basolateral
50 pS K channels through a cytochrome P450-dependent
pathway,6 and that cAMP stimulated the 50 pS K channels.8
Prostaglandins such as prostaglandin-E2 (PGE2) have been
shown to inhibit Cl transport by antagonizing vasopressin’s
effect in the TAL.9,10 Cl transport in the TAL is a two-step
process: Cl enters the cells through an Na/K/Cl co-
transporter and leaves the cells across the basolateral
membrane via Cl channels.1,11 As Cl exit across the
basolateral membrane is electrogenic, alteration of basolateral
K channel activity is expected to affect the Cl exit and
indirectly the activity of the Na/Cl/K co-transporter in the
apical membrane. Thus, it is likely that the PGE2-induced
inhibition of Cl transport in the TAL is partially mediated by
regulation of the basolateral K channels. The main goal of
this study is to examine whether PGE2 regulates the
basolateral 50 pS K channels in the TAL and to investigate
the pathway by which PGE2 regulates the K channels.
RESULTS
We first examined the effect of PGE2 on the 50 pS K channels
in the basolateral membrane of the TAL. Figure 1 is a channel
recording showing that application of 10 mM PGE2 inhibited
the 50 pS K channels in the basolateral membrane of the TAL
and reduced NPo from 0.30±0.05 to 0.04±0.03 (n¼ 5,
Po0.01). As prostaglandin E receptor 3 (EP3) has been
shown to be a major type of PGE2 receptor expressed in the
TAL,12 we next examined the effect of sulprostone (a specific
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EP1- and EP3-receptor agonist)13 on the 50 pS K channels in
the basolateral membrane of the TAL. Figure 2 is a recording
demonstrating that sulprostone (10 mM) mimicked the effect
of PGE2 and decreased NPo from 0.32±0.06 to 0.05±0.03
(n¼ 5, Po0.01). This suggests that the inhibitory effect of
PGE2 on the 50 pS K channels was mediated by stimulating
either EP1 or EP3 receptors in the TAL. Stimulation of EP3
receptor has been shown to activate pertussis toxin-sensitive
G-protein and decrease cAMP generation.14 We have
demonstrated previously that stimulation of protein
kinase-A (PKA) with the membrane-permeable cAMP analog
increased the activity of the basolateral 50 pS K channels.8 If
the inhibitory effect of PGE2 on the basolateral 50 pS K
channels was due to decrease of cAMP and inhibition of
PKA, inhibiting PKA should mimic the effect of PGE2. Thus,
we examined the effect of H8 (inhibitor of PKA) on the 50 pS
K channels in the TAL. We confirmed the previous finding
that inhibition of PKA had no significant effect on the
basolateral 50 pS K channels in the TAL (data not shown),8
suggesting that PKA did not play a role in determining the
basal activity of the basolateral K channels. In addition to
decreasing cAMP, stimulation of EP3 receptor has also been
reported to activate PKC and Rho-kinase.15,16 Thus, we
examined whether PKC was responsible for mediating the
inhibitory effect of PGE2 on the basolateral 50 pS K channels
in the medullary thick ascending limb (mTAL). We first
tested the effect of 300 nM calphostin-C on the 50 pS K
channel in the absence of PGE2. Figure 3 is a representative
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Figure 1 | A channel recording demonstrating the effect of 10 lM PGE2 on the basolateral 50 pS K channels. The experiment was
performed on a cell-attached patch and the holding potential was 20 mV (depolarization). The channel close level is indicated by a dotted
line and C. Two parts of the record indicated by numbers are extended to show the fast time resolution.
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Figure 2 | A channel recording showing the effect of 10 lM sulprostone on the basolateral 50 pS K channels. The experiment was
performed on a cell-attached patch and the holding potential was 0 mV. The channel close level is indicated by a dotted line and C.
Two parts of the record indicated by numbers are extended to show the fast time resolution.
Kidney International (2008) 74, 478–485 479
R Gu et al.: Effect of PGE2 on K channels o r i g i n a l a r t i c l e
recording showing that application of calphostin-C had no
significant effect on the basal level of channel activity
(control, 0.24±0.06 and calphostin-C, 0.26±0.06) (n¼ 3),
suggesting that PKC is not involved in determining the basal
level of the 50 pS K channel activity. However, blocking PKC
with 300 nM calphostin-C was restored the channel activity
inhibited by PGE2 (Figure 4). Data summarized in Figure 5
demonstrate that inhibition of PKC with 300 nM calphostin-C
restored channel activity to 0.26±0.03 (n¼ 4), a value which
was not significantly different from that in the control. This
strongly suggests that the inhibitory effect of PGE2 on the
basolateral 50 pS K channel was mediated by stimulation of
PKC in the TAL. Figure 5 also shows that stimulation of PKC
with 5mM phorbol 12-myristate 13-acetate significantly
decreased activity of the 50 pS K channels to 0.06±0.02
(n¼ 4, Po0.01).
Stimulation of PKC has been shown to activate mitogen-
activated protein kinase (MAPK) such as p38 and extra-
cellular signal-regulated kinase (ERK) in the colleting duct.17
To test whether p38 and ERK are also involved in mediating
Control Calphostin C
1
1. Control
2. Calphostin C
C-
C-
2 pA
0.5S
30S 5 pA
2
C
Figure 3 | A channel recording showing the effect of calphostin-C on the 50 pS K channels in the TAL. The experiment was
performed on a cell-attached patch and the holding potential was 20 mV (depolarization). The channel close level is indicated by a dotted
line and C. Two parts of the record indicated by numbers are extended to show the fast time resolution.
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Figure 4 | A channel recording demonstrating the effect of 10 lM PGE2 on the basolateral 50 pS K channels in the absence
and presence of 300 nM calphostin-C. The experiment was performed on a cell-attached patch and the holding potential was 0 mV.
The channel close level is indicated by a dotted line and C. Three parts of the record indicated by numbers are extended to show the fast
time resolution.
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the effect of PGE2 on the basolateral 50 pS K channels in
the TAL, we examined the effect of PD98059, an inhibitor
of ERK,18 on the basolateral 50 pS K channels in the TAL.
Figure 6 is a recording demonstrating that inhibiting
ERK with 50 mM PD98059 increased the 50 pS K channel
activity from 0.18±0.04 to 0.59±0.09 (n¼ 4, Po0.01). This
suggests that ERK is involved in determining the basal
activity of the basolateral 50 pS K channels in the TAL.
Alternatively, basolateral 50 pS K channels were inhibited by
ERK under control conditions and inhibition of ERK
reactivated the 50 pS K channels. We next examined the
effect of PGE2 on the basolateral 50 pS K channels in the TAL
treated with 50 mM PD98059. Although inhibition of ERK
increased the activity of the basolateral 50 pS K channels,
treatment of the TAL with PD98059 did not abolish the 10 mM
PGE2-induced inhibition of the 50 pS K channels and
decreased NPo from 0.59±0.09 to 0.3±0.07 (n¼ 4, Po0.01)
(Figure 6). However, upon examination of the time course of
the experiments, it is apparent that the onset time of PGE2
effect on the 50 pS K channels was also increased. Thus,
inhibition of ERK could not completely abolish the effect of
PGE2 on the basolateral 50 pS K channels in the TAL. We
then examined the effect of inhibiting p38 on the basolateral
50 pS K channels in the TAL. Similar to PD98059, inhibiting
p38 with 5 mM SB20358019 also increased basolateral 50 pS K
channel activity from 0.21±0.06 to 0.49±0.08 (Figure 7)
(n¼ 4, Po0.01). This suggests that p38 MAPK inhibited the
50 pS K channels under control conditions. Moreover, in the
presence of SB203580, PGE2 was still able to inhibit the 50 pS
K channels in the TAL and decreased NPo from 0.49±0.08 to
0.29±0.08 (n¼ 4, Po0.01). Thus, similar to PD98059,
inhibition of p38 alone was not sufficient to abolish the
PGE2-induced inhibition of the basolateral 50 pS K channels.
We then examined the possibility that the effect of PGE2 was
the result of stimulating both ERK and p38 MAPKs. Data
summarized in Figure 7 demonstrate that inhibition of both
p38 and ERK not only significantly increased the activity of
the basolateral 50 pS K channels from 0.18±0.05 to
0.70±0.09 (n¼ 4, Po0.001), but also abolished the PGE2-
induced inhibition of the basolateral 50 pS K channels
completely. Thus, it is suggested that PGE2 inhibits
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Figure 5 | Effect of PGE2 (10 lM), PGE2þ calphostin-C (cal.c)
(300 nM), and phorbol 12-myristate 13-acetate (5 lM) on the
basolateral 50 pS K channels. The experiments were carried out
on cell-attached patches.
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Figure 6 | A channel recording demonstrating the effect of PD98059 (50 lM) and 10 lM PGE2þPD98059 on the basolateral 50 pS K
channels in the TAL. The experiment was performed on a cell-attached patch and the holding potential was10 mV (depolarization). The channel
close level is indicated by a dotted line and C. Three parts of the record indicated by numbers are extended to show the fast time resolution.
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basolateral 50 pS K channels in the TAL through activation of
PKC–MAPK pathways.
We next used the mTAL cell line, which has been shown to
possess the properties of the native mTAL,20 to study the
effect of PGE2 on ERK and p38 phosphorylation. We treated
mTAL cell with 10 mM PGE2 for 15 min and examined the
phosphorylation of p38 and ERK. Figure 8 is a western blot
showing that application of 10 mM PGE2 stimulates phos-
phorylation of both p38 and ERK by 85±10% (n¼ 4,
Po0.05) and 50±8% (n¼ 4), respectively. Inhibition of
cyclooxygenase with 10 mM indomethacin did not signifi-
cantly affect the basal level of MAPK phosphorylation,
suggesting that endogenous PGE2 was not involved in
regulating p38 and ERK phosphorylation. Moreover, in the
presence of indomethacin, application of PGE2 still stimu-
lates p38 and ERK phosphorylation by 70±10% (n¼ 4,
Po0.05) and 50±8% (n¼ 4, Po0.05), respectively. Thus,
our results indicate that PGE2 stimulates ERK and p38
MAPK. As the inhibitory effect of PGE2 on the 50 pS K
channels was abolished by blockade of PKC, we examined
whether calphostin-C could abolish the effect of PGE2 on the
MAPK phosphorylation. We treated mTAL cells with 300 nM
calphostin-C or the vehicle for 20 min, followed by addition
of 10 mM PGE2 for 5 min in the presence or absence of
calphostin-C. As shown in Figure 9, inhibiting PKC did not
significantly affect the basal level of MAPK phosphorylation,
but it abolished the effect of PGE2 on both ERK and p38
phosphorylation. This suggests that PKC is involved in
mediating the effect of PGE2 on MAPK phosphorylation.
DISCUSSION
In this study, we have shown that PGE2 inhibited the
basolateral 50 pS K channels in the TAL and that inhibiting
PKC abolished the effect of PGE2 on the 50 pS K channel
activity. As the effect of PGE2 on the basolateral K channels
was mimicked by sulprostone, results strongly suggest that
the effect of PGE2 is mediated by stimulation of either EP1 or
EP3 receptor. Both EP1 and EP3 receptors are expressed in
the kidney.12,21 A large body of evidence indicates that EP1
receptors are mainly located in the distal nephron segment
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Figure 7 | Effect of 10 lM PGE2 on the basolateral 50 pS K
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Figure 8 | Effect of PGE2 on the phosphorylation of p38 and
ERK. Western blots show the effect of 10 mM PGE2 on the
phosphorylation of p38 (a) and ERK (b) in the presence or absence
of 10 mM indomethacin. Data are summarized in a bar graph
(bottom panel). The asterisk indicates a significant difference
in comparison with the control.
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Figure 9 | Effect of PGE2 on the phosphorylation of p38 and
ERK in the presence of PKC inhibitor. Western blots show the
effect of PGE2 on the phosphorylation of p38 (a) and ERK
(b) in the presence or absence of 300 nM calphostin-C. Data
are summarized in a bar graph (bottom panel). The asterisk
indicates a significant difference in comparison with the control.
482 Kidney International (2008) 74, 478–485
o r i g i n a l a r t i c l e R Gu et al.: Effect of PGE2 on K channels
such as the connecting tubule and collecting duct,22,23
whereas EP3 receptor is a major PG receptor in the TAL.12
It is well demonstrated that EP3 receptor is a G-protein-
coupled receptor and that stimulating EP3 receptor inhibits
adenylate cyclase and decreases cAMP generation. However,
the observation that inhibiting PKA had no significant
effect on the basolateral 50 pS K channel, suggests that PKA
is not involved in determining the basal activity of the 50
pS K channels. Thus, it is unlikely that the inhibitory effect
of PGE2 on the 50 pS K channels was the result of inhibition
of PKA, although activation of PKA stimulated the
basolateral 50 pS K channel activity in the TAL.8 In addition
to decreasing camp generation, stimulation of EP3 receptor
has also been reported to activate PKC, MAPK, and Rho-
kinase,15,16 and to increase inositol triphosphate/Ca2þ
release.24 The finding that inhibiting PKC restored the
channel activity inhibited by PGE2, strongly suggests
that PKC was responsible for mediating the effect of PGE2
on the basolateral K channels. The role of PKC in inhibiting
the basolateral 50 pS K channels is also suggested by
the observation that stimulation of PKC with phorbol
12-myristate 13-acetate inhibited the basolateral K channels.
Relevant to our observation is that PGE2 inhibited vasopres-
sin-induced stimulation of bicarbonate transport in the
mTAL by activating PKC-d.25,26 Also, we have demonstrated
that PGE2 inhibits the apical 70 pS K channels by a PKC-
dependent signaling mechanism in the TAL.27 However,
we could not completely exclude the possibility that EP1
receptor is responsible for the inhibitory effect of PGE2
on the basolateral K channels in the TAL.
This study has also demonstrated that p38 and ERK were
involved in mediating the effect of PGE2 on the basolateral 50
pS K channels in the TAL. This view is supported by two lines
of evidence: (1) PGE2 stimulated phosphorylation of p38 and
ERK in the mTAL cells and (2) inhibition of p38 and ERK
abolished the inhibitory effect of PGE2 on the 50 pS K
channels. Because inhibition of PKC abolished the effect of
PGE2 on the phosphorylation of both p38 and ERK, MAPK
may be a downstream signaling molecule, which mediates the
effect of PGE2 on the basolateral K channels. MAPK plays an
important role in the regulation of renal K channels. We have
demonstrated previously that p38 and ERK inhibited the
big conductance K channels and renal outer-modullary K
channel (Kirl.1) in the CCD.28,29 The observation that
inhibiting p38 or ERK stimulated the basolateral 50 pS K
channel activity suggests that MAPKs were involved in
determining the basal activity of the basolateral 50 pS K
channels. This is in contrast to PKC, which is not involved in
determining the basal activity of the 50 pS K channels
because inhibition of PKC did not significantly alter
basolateral K channel activity. We speculate that MAPK is
activated under control conditions (without PGE2) and
application of PGE2 causes further stimulation of MAPK by a
PKC-dependent mechanism. PKC has been shown to
stimulate MAPK in different types of cells.30,31 The mecha-
nism by which PKC stimulates MAPK in response to PGE2
is not clear. PKC has been shown to stimulate NADPH
oxidase32 and stimulation of NADPH oxidase increases
superoxide production, which is a potent stimulator for
p38 and ERK in a variety of tissues, including kidney.33
The physiological significance of this study is to illustrate
the mechanism by which PGE2 inhibits Cl absorption in the
TAL through inhibiting basolateral K channels. Figure 10 is a
cell model illustrating the way PGE2 inhibits basolateral K
channels in the TAL. Stimulation of EP1 or EP3 receptor
activates PKC, which further increases p38 and ERK activity.
As a consequence, PGE2 inhibits basolateral K channels.
PGE2-induced inhibition of the basolateral K channel activity
is expected to depolarize the basolateral cell membrane
potential and decrease the driving force for Cl exit across the
basolateral membrane. Decreasing Cl exit would raise intra-
cellular Cl concentrations, which leads to inhibition of the
Na/K/Cl co-transporter.34 A large body of evidence indicates
that PGE2 inhibits Cl absorption in the TAL.
10,35,36 The
inhibitory effect of PGE2 on Cl transport may be partially
mediated by inhibiting the Na/K/Cl co-transporter.36,37
However, it has been reported that PGE2 had no effect on
the basal level of Cl transport in the absence of vasopressin,
although it abolished vasopressin-induced stimulation of
Cl transport in the mouse medullary TAL.10 We have now
demonstrated that PGE2 may inhibit Cl absorption by
inhibiting basolateral K channel activity in the absence of
vasopressin. The discrepancy may be due to the different
concentrations of PGE2 and different part of TAL because we
used high concentrations of PGE2 and cortical TAL in our
experiments. The finding that PGE2 at high concentrations
may affect the activity of epithelial transport in the TAL, has
also been reported in our previous study.27 We have shown
that PGE2 at low concentrations (o1 mM) abolished the
stimulatory effect of vasopressin on the apical K channels in
the TAL, while 5–10 mM PGE2 inhibited apical K channels by
PKC. PGE2-induced inhibition of basolateral K channels may
be partially responsible for the inhibition of salt transport in
the TAL during K-restriction, which is known to cause
TAL
KNa
K
Cl
K
EPPKC
P38/ERK
PGE2
Na
K
Cl
Figure 10 | A cell model illustrating the mechanism by which
PGE2 inhibits the basolateral 50 pS K channels by a
PKC–MAPK pathway in the TAL.
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impairment of the epithelial transport in the Henle’s loop.
Because K-restriction increases cyclooxygenase-2 expression
and PGE2 generation in the kidney,
17 increasing PGE2
production could suppress the salt transport by inhibiting
apical K channels and the Na/K/Cl co-transporter and
basolateral K channels. We conclude that PGE2 inhibits the
basolateral 50 pS K channels and that the effect of PGE2 is
mediated by stimulating the PKC–MAPK-dependent path-
way.
MATERIALS AND METHODS
Preparation of the TAL
Pathogen-free Sprague–Dawley rats of either sex (40–50 g) were
purchased from the animal facility of the Second Affiliated Hospital
of Harbin Medical University. The rats were fed normal rat chow
and had free access to water for 7 days before experiments. Rats were
killed by cervical dislocation (the weight of rats was less than 90 g)
and kidneys were removed immediately. Thin coronal sections were
cut with a razor blade and kidney slices were incubated in a HEPES
buffer solution containing collagenase type-1A (1 mg/ml; Sigma,
St Louis, MO, USA) at 37 1C for 45–60 min. After collagenase
treatment, the kidney slices were rinsed with a solution containing
(in mM) 140 NaCl, 5 KCl, 1.5 MgCl2, 1.8 CaCl2, and 10 HEPES
(pH¼ 7.4) at 4 1C. The cortical TAL was dissected and the isolated
tubule was transferred onto a 5 5-mm cover glass coated with
polylysine (Sigma) to immobilize the tubule. The cover glass
was placed in a chamber mounted on an inverted microscope
(Nikon, Melville, NY, USA). The TAL tubules were superfused with
HEPES-buffered NaCl solution plus 5 mM glucose. The basolateral
membrane of cells, which had no sign of swelling and a clear board
to their neighbor cells, was then patched. The animal protocol
was approved by the animal use committee of Harbin Medical
University.
Patch-clamp technique
The patch pipette was pulled with Narishege PP-81 electrode puller
and the pipette solution contained (in mM) 140 KCl, 1.8 MgCl2, and
10HEPES (pH¼ 7.4). We used an Axon 200A patch-clamp amplifier
to record channel current. The current was low-pass filtered at
0.5 kHz and digitized with an Axon interface (Digidata 1200). Data
were collected with an IBM-compatible Pentium computer at a rate
of 2 kHz and analyzed using pClamp software system 7.0 (Axon
Instruments, Burlingame, CA, USA). Channel activities were defined
as NPo, a product of channel open probability (Po) and channel
number (N). NPo was calculated from data samples of 60-s duration
in the steady state as follows:
NPo ¼
X
ð1t1 þ 2t2 þ . . . itiÞ
where ti is the fractional open time spent at each of the observed
current levels. We selected a 60-s-long trace at the steady state
after the onset of PGE2 effect to calculate the channel activity.
The channel conductance was determined by measuring K current
at several different holding potentials.
Cell culture
The method used to culture mTAL cell has been described
previously.20 Briefly, mTAL cells were grown in Dulbecco’s modified
Eagle’s medium/F12(1:1) medium with 2.5 mM L-glutamine, 15 mM
HEPES, 0.5 mM sodium pyruvate, and 1.2 g/l sodium bicarbonate
supplemented with 0.005 mM dexamethasone and 5% fetal bovine
serum. mTAL cells were treated with PGE2 for 5 min. After
treatment with PGE2, cells were washed with ice-cold phosphate-
buffered saline twice and incubated for 30 min in radio-immuno-
precipitation assay lysis buffer (1 phosphate-buffered saline, 1%
Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS, 10 mg/ml
phenylmethylsulfonyl fluoride, 10 ml/ml Cocktail, 100 mM sodium
orthovanadate).
Western blot
Proteins homogenized from mTAL cells were separated by
electrophoresis on 8–10% SDS–polyacrylamide gels and transferred
to Immuno-Blot polyvinylidene difluoride membrane (Bio-Rad,
Hercules, CA, USA). The membrane was blocked with Odyssey
blocking buffer for fluorescent western blotting (Rockland, Gilberts-
ville, PA, USA) and incubated with the primary antibody at 4 1C for
12 h. The membrane was washed four times (5 min for each wash)
with phosphate-buffered saline containing 0.1% Tween-20, followed
by incubation with the secondary antibody for an additional 30 min.
The membrane was then washed three times (10 min for each wash)
with phosphate-buffered saline and scanned by Odyssey infrared
imaging system (LI-COR, Lincoln, NE, USA) at wavelength of 680
or 800 nm.
Experimental solutions and statistics
Phorbol 12-myristate 13-acetate, PGE2, sulprostone, calphostin-C,
SB203580, and PD98059 were purchased from Biomol (Plymouth
Meeting, PA, USA) and dissolved in either ethanol or dimethyl-
sulfoxide solution. The final concentration of ethanol or dimethyl-
sulfoxide was less than 0.1% and had no effect on channel activity.
Data are shown as mean±s.e.m. We used either Student’s t-test
or one-way analysis of variance to determine the significance
between the two groups. Po0.05 was considered statistically
significant.
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